New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2013
06:11 EDTCTRXCatamaran recent pullback overdone, says Jefferies
Jefferies views the recent sell-off in shares of Catamaran as overdone as it believes concerns over the company's ability to meet 2014 consensus estimates are fully priced in at current levels. The firm keeps a Buy rating on the stock with a $65 price target.
News For CTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
06:09 EDTCTRXCatamaran reports Q1 adjusted EPS 59c, consensus 57c
Subscribe for More Information
April 29, 2015
15:00 EDTCTRXNotable companies reporting before tomorrow's open
Subscribe for More Information
April 27, 2015
07:13 EDTCTRXUBM Tech to hold a conference
Subscribe for More Information
April 23, 2015
12:08 EDTCTRXLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
April 22, 2015
10:02 EDTCTRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTCTRXCatamaran downgraded to Hold from Buy at Maxim
Maxim downgraded Catamaran to Hold citing the takeover by OptumRx as it does not believe another suitor will emerge with a counter bid.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use